Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses-Reference-Cited by-同舟云学术

Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses

Published:2023-09 Issue: Volume:217 Page:105701
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ivashchenko Andrei A.,Jones Jeremy C.,Shkil Dmitry O.,Ivanenkov Yan A.,Pascua Philippe Noriel Q.,Penaflor Melissa K.,Karapetian Ruben N.,Govorkova Elena A.^ORCID,Ivachtchenko Alexandre V.

Funder

U.S. Department of Health and Human Services

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference29 articles.

1. A review of clinical influenza A and B infections with reduced susceptibility to both oseltamivir and zanamivir;Abed;Open Forum Infect. Dis.,2017

2. Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021;Adlhoch;Euro Surveill.,2021

3. Influenza therapeutics in clinical practice-challenges and recent advances;Beigel;Cold Spring Harb Perspect Med,2021

4. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y;Burnham;Antimicrob. Agents Chemother.,2014

5. Centers for Disease Control and Prevention, N.C.f.I.a.R.D.N, Effectiveness of Seasonal Flu Vaccines from the 2004–2021 Flu Seasons. , CDC Seasonal Flu Vaccine Effectiveness Studies.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Prospects of Furin Inhibitors for Therapeutic Applications;International Journal of Molecular Sciences;2024-08-24